Cipollone v. Liggett Group: Preemption Ruling and Legacy

Cipollone v. Liggett Group, Inc., 505 U.S. 504 (1992), is the Supreme Court decision that decided when federal cigarette labeling laws block smokers from suing tobacco companies under state law. Decided June 24, 1992, the ruling split the difference: the 1969 federal labeling act preempts failure-to-warn claims and certain fraud claims tied to cigarette advertising, but it does not preempt claims for breach of express warranty, intentional fraud, or conspiracy to conceal health information. That dividing line still governs product liability litigation across tobacco, pharmaceuticals, medical devices, and consumer goods.

The Lawsuit Behind the Case

Rose Cipollone started smoking in 1942 and was diagnosed with lung cancer decades later. She died in 1984. Her husband Antonio filed suit in New Jersey federal court under diversity jurisdiction, and after his death their son Thomas continued the case as executor. The defendants were Liggett Group, Inc., Philip Morris, Inc., and Lorillard, Inc.¹

The complaint raised several New Jersey law theories: breach of express warranties made in cigarette advertising, failure to warn about smoking’s health risks, fraudulent misrepresentation of those risks, and conspiracy to hide medical and scientific information from the public.²

The tobacco companies had one main answer to all of it. They argued that federal cigarette labeling laws preempted the state claims, meaning Congress had already occupied the field and no state court could add to what federal law required.

The Preemption Question

The Supremacy Clause gives federal law priority over conflicting state law, and preemption is the doctrine courts use to decide when that displacement actually happens. Express preemption is when Congress says so directly. Implied preemption is when courts infer it from a federal statute’s structure or purpose.

Two federal statutes sat at the center of Cipollone. The Federal Cigarette Labeling and Advertising Act of 1965 required health warnings on cigarette packages and included a preemption clause providing that no statement relating to smoking and health could be required in cigarette advertising beyond what federal law already mandated.³

The Public Health Cigarette Smoking Act of 1969 amended that language. The new clause said: “No requirement or prohibition based on smoking and health shall be imposed under State law with respect to the advertising or promotion of any cigarettes” whose packages complied with federal labeling requirements.³

The shift from “no statement shall be required” to “no requirement or prohibition shall be imposed under State law” was the whole fight. The companies said both statutes barred the Cipollone claims. The estate said common law damages are not “requirements” imposed by a state at all, so neither statute reached them.

What the Supreme Court Held

The decision was fractured. Justice Stevens wrote the opinion. Parts I through IV drew a seven-justice majority, but the operative preemption holdings in Parts V and VI were a plurality joined only by Chief Justice Rehnquist and Justices White and O’Connor. Justice Blackmun, joined by Kennedy and Souter, would have preempted nothing. Justice Scalia, joined by Thomas, would have preempted more.¹

The plurality reached two main conclusions.

First, the 1965 Act’s preemption clause did not block state common law damages actions. It reached only positive enactments by rulemaking bodies that would have mandated particular warnings on packages or in advertisements.¹

Second, the broader 1969 language did preempt some state claims but not others. The question for each claim was whether it effectively imposed a “requirement or prohibition” on cigarette advertising or promotion.

Claims That Were Preempted

Failure-to-warn claims, whether framed as negligence or strict liability, that depended on showing the companies’ post-1969 advertising should have included additional or clearer warnings.
Fraudulent misrepresentation claims alleging that cigarette advertising neutralized the effect of the federally mandated warning labels.

Claims That Survived

Breach of express warranty claims, because the duty came from promises the manufacturers voluntarily made, not from anything state law imposed on them.
Fraudulent misrepresentation claims based on intentional false statements or concealment of material facts, because those rested on the general duty not to deceive rather than a duty tied to cigarette advertising content.
Conspiracy claims to conceal health information from the public.²

The Court reversed the judgment below in part, affirmed it in part, and sent the case back for further proceedings.

How the Court Got There

The plurality started with a principle that became one of the decision’s most cited legacies: a presumption against preemption of state police power regulations. Where a federal statute touches an area states have traditionally regulated, such as consumer safety and tort liability, courts should not read that statute to displace state law unless Congress clearly meant to.⁴

Applying that presumption, the plurality read the 1965 Act narrowly. “No statement shall be required” reached only affirmative state regulations forcing specific warnings onto packages or ads. A jury verdict in tort is not the same thing as a state regulation prescribing what an ad must say, even if the verdict might influence a manufacturer’s future behavior. Every common law claim survived the 1965 Act on that logic.

The 1969 amendment came out differently. Congress had swapped “no statement shall be required” for “no requirement or prohibition shall be imposed under State law.” The plurality found that “requirement or prohibition” was broad enough to reach the obligations common law tort claims create, and “State law” naturally covers common law duties enforced through litigation, not just statutes.²

Even so, the plurality drew careful lines. Failure-to-warn claims were preempted because they would effectively require manufacturers to say something different or additional in their advertising, which is exactly what Congress prohibited states from demanding. Express warranty claims survived because those duties were self-imposed when the companies made specific promises in their ads. A company that voluntarily tells consumers its product is safe cannot use federal preemption to escape that promise when it turns out to be false.

Fraudulent misrepresentation split into two categories. Claims that advertising neutralized federally mandated warnings were preempted, since they challenged what the ads said about health risks. Claims that manufacturers lied outright or concealed material facts were not, because the duty not to defraud exists independently of any smoking-and-health rule.

The Justices Who Disagreed

Justice Scalia, joined by Justice Thomas, called the presumption against preemption a newly invented principle that distorted the statute’s plain meaning. In his view, courts should read preemption clauses according to their apparent meaning, and doing so would mean the 1965 Act already preempted failure-to-warn claims while the 1969 Act preempted everything the plaintiff had brought.⁴

Justice Blackmun, joined by Justices Kennedy and Souter, went the other way. They read Congress as trying only to prevent states from imposing positive regulatory requirements, not to shut down tort liability at all.

What Happened to the Cipollone Family

The ruling did not end the case, but it did narrow it. Before it ever reached the Supreme Court, a New Jersey jury had found Rose Cipollone 80 percent responsible for her own injuries and Liggett Group 20 percent responsible, an allocation that barred recovery on the failure-to-warn claim under state comparative fault rules then in effect. The jury did find that Liggett breached express warranties about the health aspects of its cigarettes, awarding $0 to Rose’s estate but $400,000 to Antonio for loss of his wife’s companionship.⁵

After the Supreme Court sent the case back, with several claims barred and a difficult factual record ahead, the Cipollone family discontinued the litigation. There was no final recovery. The decision that opened doors for future plaintiffs did not deliver a win to the family that fought for it.

Why Cipollone Still Matters

The framework has traveled well beyond tobacco. Whenever a federally regulated industry argues that federal labeling or advertising rules preempt state tort claims, courts still ask the Cipollone question: does the common law claim impose a “requirement” under state law within the meaning of the federal preemption clause?

Medical Devices

Four years later, in Medtronic, Inc. v. Lohr (1996), the Supreme Court took up preemption under the Medical Device Amendments to the Federal Food, Drug, and Cosmetic Act. The Court applied the Cipollone framework directly and read the medical device statute’s use of “requirements” as tied to device-specific regulations rather than general common law duties, distinguishing it from the broader 1969 cigarette language. Medtronic also endorsed the presumption against preemption that Cipollone had introduced, cementing it as a working principle despite Justice Scalia’s continuing objections.⁶

Later Tobacco Fraud Claims

The Court returned to the framework in Altria Group, Inc. v. Good (2008), a case about “light” cigarette marketing brought under state consumer fraud law. The analysis tracked Cipollone’s line between claims challenging federally regulated advertising content, which are preempted, and claims based on the general duty not to deceive, which are not. The fraud claims in Altria survived on the second side of that line.⁷

Congress Rewrites the Rules in 2009

Congress reshaped the tobacco preemption landscape in 2009 with the Family Smoking Prevention and Tobacco Control Act, which gave the FDA broad authority over tobacco manufacturing, marketing, and distribution. The Act amended the 1965 labeling statute to give states more room to restrict cigarette advertising and promotion based on health concerns, reversing part of the hands-off approach Congress had taken in 1969.⁸

The 2009 Act set its own preemption boundaries. States cannot impose requirements different from or in addition to federal standards on tobacco product labeling, premarket review, manufacturing standards, or modified risk tobacco products. States do keep authority over the sale, distribution, advertising placement, and use of tobacco products, including age restrictions and information-reporting rules.⁹

The core of Cipollone survives that overhaul in one important place: failure-to-warn claims based on post-1969 cigarette advertising and promotion remain preempted. The 2009 Act did not retroactively bring them back. Plaintiffs suing cigarette makers today still work through the paths Cipollone left open, which means express warranty, intentional fraud, and conspiracy, rather than arguing the companies should have used different warnings.

What Cipollone contributed, and what still holds, is a method for working through the tension between federal uniformity and state consumer protection: read the preemption clause carefully, apply a presumption against displacing state law, and separate claims that challenge what federal law specifically regulates from claims that enforce general legal duties Congress never set out to replace.

1
Justia U.S. Supreme Court Center. Cipollone v. Liggett Group, Inc., 505 U.S. 504 (1992)
2
Cornell Law School Legal Information Institute. Cipollone v. Liggett Group, 505 U.S. 504 (1992)
3
Office of the Law Revision Counsel. 15 U.S. Code 1334 – Preemption
4
Cornell Law School Legal Information Institute. Cipollone v. Liggett Group, 505 U.S. 504 (1992) – Scalia Concurrence/Dissent
5
Justia Law. Cipollone v. Liggett Group, Inc., 693 F. Supp. 208 (D.N.J. 1988)
6
Legal Information Institute. Medtronic, Inc. v. Lohr et vir, 518 U.S. 470 (1996)
7
Legal Information Institute. Altria Group, Inc. v. Good
8
U.S. Food and Drug Administration. Cigarette Labeling and Health Warning Requirements
9
Office of the Law Revision Counsel. 21 U.S. Code 387p – Preservation of State and Local Authority